Since NR4A and MUC5B are not only expressed in the DLBCL cells but also in non-malignant cells, we cannot exclude that estrogen effects on expression in non-malignant cells, e.g., cells of the immune system, contribute to the response [47,48,49,50]. The gene discussed is MUC5B; the disease is diffuse large B-cell lymphoma.